Stay ConnectedInterviews with the scientists, founders and investors driving Human 3 – the next epoch of health, wellbeing and performance.
Topics include brain-computer interfaces, genetic medicine, psychedelics, longevity, AI and more.
Hosted by Brom Rector and Sam Tabone – founders of XEIA Venture Partners, a venture capital fund investing in Human 3.
More at www.xeiavp.com
Copyright: © Brom Rector and Empath Ventures
Tom Feegel is the Founder and CEO of Beond. Beond exists to help end the opiate addiction epidemic with safe ibogaine treatment.
In this episode Tom speaks on the severity of the opioid epidemic and explains how ibogaine assisted therapy can help heal those who are suffering from addiction. Tom gets into his personal story, how Ibogaine helped someone in his family, the economics of addiction treatment and Beond's plans to scale into a global operation.
Dillan DiNardo is the CEO of Mindstate Design Labs - a preclinical-stage biotechnology company developing the next generation of psychedelic-inspired therapeutics for intractable mental health conditions.
Mindstate's mission is to map the biological basis of the varieties of psychedelic experience, and to use that map to pharmacologically design therapeutic states of mind to be applied in medically supervised settings to heal the root causes of mental health disorders. Mindstate participated in Y Combinator in 2021.
Check out Mindstate @ https://www.mindstate.design/
Mental health treatment is often inaccessible, inadequate, and ineffective. However, Nue Life is working to change this through its 360-degree approach to patient health, leveraging ketamine and the integration of tech.
Check out Nue.Life here: https://nue.life/
⏰ Timestamps:
0:00 intro and Juan Pablo’s backstory
5:30 how Nue Life got started
11:00 the Nue Life patient experience
20:40 the intersection of data and mental health
32:30 competition in the Ketamine landscape
37:00 is ketamine addictive?
45:00 the future of at-home ketamine and the Ryan Haight act
49:15 legal psilocybin in Oregon?
53:30 what’s next for Nue Life?
Our TOPPODCAST Picks 
